Yousif Capital Management’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$257K	Sell	11,386 -657	-5%	-$14.6K	﹤0.01%	1671
2025 Q4	$232K	Sell	12,043 -2,147	-15%	-$51.1K	﹤0.01%	1727
2025 Q3	$366K	Sell	14,190 -3,366	-19%	-$82.7K	﹤0.01%	1558
2025 Q2	$420K	Sell	17,556 -49	-0.3%	-$1.24K	﹤0.01%	1539
2025 Q1	$437K	Sell	17,605 -454	-3%	-$10.9K	0.01%	1495
2024 Q4	$340K	Sell	18,059 -446	-2%	-$7.83K	﹤0.01%	1636
2024 Q3	$279K	Sell	18,505 -435	-2%	-$7.44K	﹤0.01%	1757
2024 Q2	$542K	Sell	18,940 -2,105	-10%	-$59.9K	0.01%	1439
2024 Q1	$615K	Sell	21,045 -2,150	-9%	-$66K	0.01%	1430
2023 Q4	$783K	Sell	23,195 -565	-2%	-$16.5K	0.01%	1344
2023 Q3	$729K	Sell	23,760 -1,342	-5%	-$48.4K	0.01%	1299
2023 Q2	$1.01M	Sell	25,102 -1,578	-6%	-$65.2K	0.01%	1157
2023 Q1	$1.09M	Sell	26,680 -3,375	-11%	-$134K	0.01%	1107
2022 Q4	$1.16M	Sell	30,055 -6,995	-19%	-$340K	0.02%	1088
2022 Q3	$1.97M	Sell	37,050 -309	-0.8%	-$17.2K	0.03%	745
2022 Q2	$2.18M	Sell	37,359 -3,410	-8%	-$223K	0.03%	759
2022 Q1	$3.11M	Buy	40,769 +865	+2%	+$57.7K	0.03%	609
2021 Q4	$2.4M	Buy	+39,904	New	+$2.2M	0.02%	846